Skip to main content
. 2022 Jun 28;153:113350. doi: 10.1016/j.biopha.2022.113350

Fig. 1.

Fig. 1

Workflow the current study. a) the schematics of Sar-CoV-2 virus structure and its pathogenesis in alveoli with different stages, and b) different drug repurposing methods for Sar-CoV-2 discussed in the present study.